| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-05 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |